ADIPOQ and obesity disorder: Obesity alters the profile of these molecules, leading to an increase in pro-inflammatory adipokines such as leptin, chemerin, and visfatin, while levels of adiponectin and omentin, which exert counterbalancing anti-inflammatory effects, are typically reduced [11,13,14].